J 2017

Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature

CHOVANCOVÁ, Zita, Pavlina KRALICKOVA, Alena PEJCHALOVÁ, Marketa BLOOMFIELD, Jana NECHVÁTALOVÁ et. al.

Basic information

Original name

Selective IgM Deficiency: Clinical and Laboratory Features of 17 Patients and a Review of the Literature

Authors

CHOVANCOVÁ, Zita (203 Czech Republic, guarantor, belonging to the institution), Pavlina KRALICKOVA (203 Czech Republic), Alena PEJCHALOVÁ (203 Czech Republic), Marketa BLOOMFIELD (203 Czech Republic), Jana NECHVÁTALOVÁ (203 Czech Republic, belonging to the institution), Marcela VLKOVÁ (203 Czech Republic, belonging to the institution) and Jiří LITZMAN (203 Czech Republic, belonging to the institution)

Edition

Journal of Clinical Immunology, New York, Springer, 2017, 0271-9142

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 4.227

RIV identification code

RIV/00216224:14110/17:00098289

Organization unit

Faculty of Medicine

UT WoS

000407597600011

Keywords in English

Selective IgM deficiency; primary immunodeficiency; infections; autoimmunity; allergy

Tags

Tags

International impact, Reviewed
Změněno: 7/3/2018 16:08, Soňa Böhmová

Abstract

V originále

Primary selective IgM deficiency (sIgMD) is a primary immunodeficiency with unclear pathogenesis and a low number of published cases. We reviewed clinical and laboratory manifestations of 17 sIgMD patients. Serum IgM, IgG, and its subclasses, IgA, IgE, antibodies against tetanus toxoid, pneumococcal polysaccharides and Haemophilus influenzae type b, isohemagglutinins, and T and B lymphocyte subsets, expressions of IgM on B cells and B lymphocyte production of IgM were compared with previously reported case reports and a small series of patients, which included 81 subjects in total. We found that some patients in our cohort (OC) and published cases (PC) had increased IgE levels (OC 7/15; PC 21/37), decreased IgG4 levels (OC 5/14), very low titers of isohemagglutinins (OC 8/8; PC 18/21), increased transitional B cell counts (OC 8/9), decreased marginal zone B cell counts (OC 8/9), and increased 21(low) B cell counts (OC 7/9). Compared with the PC (20/20), only two of five OC patients showed very low or undetectable production of IgM after stimulation. A majority of the patients had normal antibody production to protein and polysaccharide antigens, basic lymphocyte subset counts, and expression of surface IgM molecules on B cells. Low IgM levels are associated with various immunopathological disorders; however, pathogenic mechanisms leading to decreased IgM serum level in selective IgM deficiency remain unclear. Moreover, it is difficult to elucidate how strong these associations are and if these immunopathological conditions are primary or secondary.